Testing Drug Resistance in Streptococci and Enterococci
Author Information
Author(s): Brigante Gioconda R, Luzzaro Francesco A, Pini Beatrice, Lombardi Gianluigi, Sokeng Gertrude, Toniolo Antonio Q
Primary Institution: Laboratorio di Microbiologia, Università dell'Insubria e Ospedale di Circolo, Varese, Italy
Hypothesis
The study aims to evaluate the drug susceptibility of clinical isolates of streptococci and enterococci using the Phoenix automated microbiology system.
Conclusion
The Phoenix system is an effective tool for quantitative antimicrobial susceptibility testing of clinically relevant streptococcal and enterococcal species.
Supporting Evidence
- The Phoenix system showed essential agreement rates of 91.9% for streptococci and 97% for enterococci.
- Categorical agreement rates were 98.8% for streptococci and 96% for enterococci.
- The mean time to results was 11.8 hours, indicating rapid testing capabilities.
Takeaway
The Phoenix system helps doctors quickly find out which medicines can fight infections caused by certain bacteria.
Methodology
The study used the Phoenix automated microbiology system to test the drug susceptibility of 250 clinical isolates of streptococci and enterococci.
Limitations
The study may have limitations related to the small number of certain species tested and the potential for minor errors in susceptibility results.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website